Growth patterns during the first two years of a child's life may shape pubertal growth and adult height, but have little ...

Childhood nutrition plays a critical role in healthy growth, while also helping to establish lifelong eating habits that can cut the risk of chronic diseases.

Somapacitan was noninferior to somatropin in improving yearly growth rate in children born SGA, or with NS or ISS. Topline data were announced from a phase 3 trial evaluating somapacitan in pre ...

At Children’s Hospital of Philadelphia, Executive Vice President and CFO Sophia Holder is entering her fifth year in the role with pediatric growth opportunities on her mind, and a goal of continuing ...

With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in ...

Novo Nordisk reported positive data from a late-stage trial of its once-weekly Sogroya treatment for children with growth disorders. The Danish pharmaceutical giant said the drug was more effective ...

By Robert Andre Emmanuel [email protected] The Ministry of Health, Wellness, the Environment and Civil Service Affairs has partnered wit ...

Topline data were announced from a phase 3 trial evaluating somapacitan in children born small for gestational age, with Noonan syndrome, or with idiopathic short stature.